BOMAZINE 20 SEDATIVE INJECTION FOR CATTLE, DOGS AND CATS

País: Austrália

Língua: inglês

Origem: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingredientes ativos:

xylazine as HCl(20mg/mL)

Disponível em:

BOMAC/PHARM TECH

DCI (Denominação Comum Internacional):

xylazine as HCl(20mg/mL)

Forma farmacêutica:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Unidades em pacote:

50mL

Classe:

Veterinary Medicine

Fabricado por:

BAYER AUSTRALIA

Grupo terapêutico:

CAT | CATTLE | DOG | BEEF | BITCH | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | CASTRATE | CAT - QUEEN

Área terapêutica:

analgesic,sedative

Indicações terapêuticas:

ANALGESIC | ANTIPYRETIC | COLIC | MUSCLE RELAXANT | SEDATIVE | SPASMOLYTIC

Resumo do produto:

For the sedation, analgesia and muscle relaxation of cattle, dogs and cats.Not recommended on animals with cardiovascular disease, respiratory depression, shock and in late pregnancy.

Status de autorização:

Registered but not available

Data de autorização:

1999-03-11

Folheto informativo - Bula

DRAFT
LABFL
18/L/99
Page
1
of
2
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
iv
i.’
(*ItV&
’
1
SEDATIVELFOR CATTLE,
DOGS AND CATS
ACTIVE
CONSTITUENT
20mg/mL
XYLAZINE (as hydrochloride)
50ML
FOR FULL DIRECTIONS READ THE ENCLOSED
LEAFLET BEFORE USING THIS PRODUCT.
WITHHOLDING
PERIODS
MEAT: DO NOT USE LESS THAN 28 DAYS BEFORE SLAUGHTER
FOR HUMAN CONSUMPTION.
MILK: MILK COLLECTED FROM COWS WITHIN 7 DAYS FOLLOWING
TREATMENT MUST NOT BE USED FOR HUMAN CONSUMPTION
E;LPRERESSING. THIS MILK SHOULD NOT BE FED TO BOBBY
.
Distributed
by
PharmTech
Pty Ltd, 8 Apollo Avenue, West Pymble, Sydney,
NSW,
Australia
FreeCall
1800 624 713
ACN No.
0
1997
DISPOSAL
Dispose of empty container by wrapping with paper and
placing in garbage.
STORAGE
Store below
25°C
(Air Conditioning).
Protect from light.
NRAApproval
No.
40646/0x??
Q
Exp.
2394-2
PRESCRIPTION
ANIMAL
REMEDY
CONTRAINDICATIONS
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
B10~~YFNE20
SEDATIVE
KOOR CATTLE, DOGS AND CATS
X
Not recommended on
an.__,als
with cardiovascular disease, respiratory depression, shock and in
late pregnancy.
2
?I
PRECAUTIONS
Heavy salivation can occur in cattle, therefore take necessary steps
to avoid inhalation
pneumonia.
DESCRIPTION
A clear
colourless
solution.
Each mL contains Xylazine hydrochloride
23.37mg,
equivalent to Xylazine base 20mg.
MODE OF ACTION
Xylazine is a sedative with variable analgesic and muscle relaxant
properties depending on the
species and temperament of the animal injected and also on the dosage
and route of injection
employed. The major affect is on presynaptic alphaZadrenergic
receptors in the central nervous
system by causing inhibition of the release of noradrenaline from the
nerve endings. It also
produces muscle relaxation by inhibition of the central intraneuronal
transmission of nerve
impulses. Xylazine stimulates the emetic centre in the cat and
occasionally the dog.
Xylazine can be used on its own or in combination with other
sedatives, analgesics and
anaesthetics to pr